Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
High-Dose Aflibercept in Wet AMD and DME Provide Therapeutic Benefits, No New Safety Signals - AJMC.com Managed Markets Network
+ 104 more
2/12/23 at 1:35am
Organization
Ajmc.com
Authors
Laura Joszt
MA
57 words
0
Comments
Two studies looking at a higher dose of aflibercept found that an 8 mg dose can most be maintained at longer dosing intervals with similar benefits and no additional safety signals compared with the 2 mg dose.
Business & Industrial
Drugs & Medications
Aflibercept
Wet AMD
Safety Signals
DME Provide Therapeutic Benefits
Markets Network Two
dosing intervals
You are the first to view
https://www.ajmc.com/view/high-dose-aflibercept-in-wet-amd-and-dme-provide-therapeutic-benefits-no-new-safety-signals
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...